Financhill
Sell
34

ARMP Quote, Financials, Valuation and Earnings

Last price:
$1.84
Seasonality move :
3.42%
Day range:
$1.81 - $2.00
52-week range:
$0.90 - $3.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
797.55x
P/B ratio:
--
Volume:
24K
Avg. volume:
495.7K
1-year change:
-37.42%
Market cap:
$69.9M
Revenue:
--
EPS (TTM):
-$0.83

Earnings Data

Next earnings date for ARMP
Aug 13
2025
Most recent earnings per share
-$0.20
Beat by $0.18
(May 14/2025)
Consensus Estimate
-$0.38
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARMP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/13/2025 Q2 $1.4M -- -- -$0.39 --
05/14/2025 Q1 $1.4M -- -$0.20 -$0.38 $0.18
03/20/2025 Q4 $1.6M -- -$0.23 -$0.35 $0.12
11/13/2024 Q3 $900K -- -$0.15 -- --
08/13/2024 Q2 $1.1M -- -$0.25 -$0.36 $0.11
05/07/2024 Q1 $1.1M -- -$0.69 -$0.31 -$0.38
03/21/2024 Q4 $860K -- -$0.55 -$0.34 -$0.21
11/14/2023 Q3 -- -- -$0.86 -$0.31 -$0.55
08/14/2023 Q2 -- -- -$0.17 -$0.38 $0.21
05/11/2023 Q1 -- -- -$0.40 -$0.32 -$0.08
03/17/2023 Q4 -- -- -$0.29 -$0.28 -$0.01
11/09/2022 Q3 -- -- -$0.24 -$0.28 $0.04
08/11/2022 Q2 -- -- -$0.26 -$0.23 -$0.03
05/12/2022 Q1 -- -- -$0.30 -- --
03/18/2022 Q4 -- -- -$0.23 -- --
11/10/2021 Q3 -- -- -$0.22 -- --
08/12/2021 Q2 -- -- -$0.25 -- --
05/13/2021 Q1 -- -- -$0.27 -- --
03/18/2021 Q4 -- -- -$0.36 -- --
11/12/2020 Q3 -- -- -$0.31 -- --
08/13/2020 Q2 -- -- -$0.26 -- --
05/14/2020 Q1 -- -- -$0.49 -- --
03/19/2020 Q4 -- -- -$0.48 -- --
11/12/2019 Q3 -- -- -$0.73 -- --
08/14/2019 Q2 -- -- -$0.69 -- --
05/06/2019 Q1 -- -- -$0.80 -- --
12/31/2018 Q4 -- -- $1.51 -- --
09/30/2018 Q3 -- -- -$0.60 -- --
06/30/2018 Q2 -- -- -$2.66 -- --
03/31/2018 Q1 -- -- -$3.36 -- --
12/31/2017 Q4 -- -- -$0.56 -- --
09/30/2017 Q3 -- -- -$1.26 -- --
06/30/2017 Q2 -- -- -$20.44 -- --
03/31/2017 Q1 -- -- -$27.16 -- --
12/31/2016 Q4 -- -- -$106.40 -- --
09/30/2016 Q3 -- -- -$45.22 -- --
06/30/2016 Q2 -- -- -$109.48 -- --
03/31/2016 Q1 -- -- -$115.08 -- --
12/31/2015 Q4 -- -- -$75.60 -- --
09/30/2015 Q3 -- -- -$42.00 -- --
06/30/2015 Q2 -- -- $46.20 -- --

Armata Pharmaceuticals Earnings Questions

  • How Much did Armata Pharmaceuticals Generate in Revenue Last Quarter?

    Armata Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Armata Pharmaceuticals Beat Earnings Last Quarter?

    Armata Pharmaceuticals announced earnings per share of -$0.20 which represents a beat of analyst forecast a -$0.38 per share.

  • Is Armata Pharmaceuticals Profitable?

    Armata Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Armata Pharmaceuticals EPS Next Year?

    Armata Pharmaceuticals's earnings are forecast to decrease from -$0.89 per share to -$0.95 per share next year representing a decrease of -117.98%.

  • When is Armata Pharmaceuticals's Earnings Date?

    Armata Pharmaceuticals's next earnings date is August 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Kestra Medical Stock Be in 1 Year?
Where Will Kestra Medical Stock Be in 1 Year?

Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…

Why Did Howard Marks Buy Grab Stock?
Why Did Howard Marks Buy Grab Stock?

When a legendary value investor who cut his teeth in…

Why Did Warren Buffett Buy Amazon Stock?
Why Did Warren Buffett Buy Amazon Stock?

When investors think of tech stocks in Warren Buffett’s portfolio,…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
88
CDTX alert for Jun 24

Cidara Therapeutics [CDTX] is up 3.18% over the past day.

Sell
46
HIMS alert for Jun 24

Hims & Hers Health [HIMS] is up 2.26% over the past day.

Buy
67
WGS alert for Jun 24

GeneDx Holdings [WGS] is up 13.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock